Yixintang Pharmaceutical Group Co Ltd
SZSE:002727

Watchlist Manager
Yixintang Pharmaceutical Group Co Ltd Logo
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Watchlist
Price: 14.43 CNY -2.83%
Market Cap: 8.5B CNY
Have any thoughts about
Yixintang Pharmaceutical Group Co Ltd?
Write Note

Yixintang Pharmaceutical Group Co Ltd
Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Yixintang Pharmaceutical Group Co Ltd
Minority Interest Peer Comparison

Comparables:
D
603233
603883
603939
301017
A
301408

Competitive Minority Interest Analysis
Latest Figures & CAGR of Competitors

Company Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Minority Interest
ÂĄ168.6m
CAGR 3-Years
126%
CAGR 5-Years
102%
CAGR 10-Years
56%
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Minority Interest
ÂĄ1.3B
CAGR 3-Years
63%
CAGR 5-Years
79%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Minority Interest
ÂĄ661.2m
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Minority Interest
ÂĄ697.6m
CAGR 3-Years
26%
CAGR 5-Years
33%
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Minority Interest
ÂĄ74.2m
CAGR 3-Years
93%
CAGR 5-Years
82%
CAGR 10-Years
N/A
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Minority Interest
ÂĄ33m
CAGR 3-Years
417%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Yixintang Pharmaceutical Group Co Ltd's Minority Interest?
Minority Interest
168.6m CNY

Based on the financial report for Jun 30, 2024, Yixintang Pharmaceutical Group Co Ltd's Minority Interest amounts to 168.6m CNY.

What is Yixintang Pharmaceutical Group Co Ltd's Minority Interest growth rate?
Minority Interest CAGR 10Y
56%

Over the last year, the Minority Interest growth was 47%. The average annual Minority Interest growth rates for Yixintang Pharmaceutical Group Co Ltd have been 126% over the past three years , 102% over the past five years , and 56% over the past ten years .

Back to Top